SCHEMBL845039

SCHEMBL845039

O=C(Nc1ccc(/C=C/c2ccc(NC(=O)[C@@H]3CCCN3C(=O)c3cccc4ccccc34)cc2)cc1)[C@@H]1CCCN1C(=O)c1cccc2ccccc12

nearest known ligand 0.51

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.51
ALDH1A1 P00352 3/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
CA12 O43570 1/20 0.45
CA2 P00918 1/20 0.45
CA9 Q16790 1/20 0.45
MAPK1 P28482 1/20 0.44
HTT P42858 1/20 0.44
HCRTR1 O43613 1/20 0.44
HCRTR2 O43614 1/20 0.44
MAPT P10636 1/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL872532 0.91 TRPV1 (0.44) TRPV1ALDH1A1CYP2C9CYP2C19CA12
SCHEMBL845008 0.86 ALDH1A1 (0.54) ALDH1A1CYP2C9CYP2C19MAPK1HTT
SCHEMBL845257 0.85 TRPV1 (0.48) TRPV1ALDH1A1CYP2C9CYP2C19MAPK1
SCHEMBL844996 0.85 CYP2C9 (0.50) TRPV1ALDH1A1CYP2C9CYP2C19MAPK1
SCHEMBL845443 0.85 CYP2C9 (0.47) TRPV1ALDH1A1CYP2C9CYP2C19MAPK1
SCHEMBL845501 0.84 HCRTR1 (0.47) TRPV1ALDH1A1CYP2C9CYP2C19MAPK1
SCHEMBL845026 0.84 CYP2C9 (0.43) TRPV1ALDH1A1CYP2C9CYP2C19MAPK1
SCHEMBL845007 0.83 PABPC1 (0.49) TRPV1ALDH1A1CYP2C9CYP2C19MAPK1
SCHEMBL845131 0.83 PABPC1 (0.49) TRPV1ALDH1A1CYP2C9CYP2C19MAPK1
SCHEMBL845013 0.83 CYP2C9 (0.46) TRPV1ALDH1A1CYP2C9CYP2C19MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8143288-B2 Inhibitors of HCV replication BRISTOL-MYERS SQUIBB COMPANY (US) 2012-03-27 US disclosed
EP-1893573-B1 INHIBITORS OF HCV REPLICATION BRISTOL MYERS SQUIBB CO (US) 2010-07-21 EP disclosed